Publication:
Soluble TRAIL and BAFF Levels in Multiple Sclerosis During Interferon-Beta Therapy

dc.contributor.authorKurne, Ash
dc.contributor.authorAydin, Oemer Faruk
dc.contributor.authorGuec, Dicle
dc.contributor.authorSayat, Gueliz
dc.contributor.authorCanpinar, Hande
dc.contributor.authorYoeruebulut, Mehmet
dc.contributor.authorKarabudak, Rana
dc.date.accessioned2020-06-21T15:12:57Z
dc.date.available2020-06-21T15:12:57Z
dc.date.issued2008
dc.departmentOMÜen_US
dc.department-temp[Kurne, Ash -- Sayat, Gueliz -- Karabudak, Rana] Hacettepe Univ Hosp, Dept Neurol, Neuroimmunol Unit, Ankara, Turkey -- [Aydin, Oemer Faruk] Ondokuz Mayis Univ, Fac Med, Dept Pediat, Samsun, Turkey --en_US
dc.description.abstracten_US
dc.identifier.endpage138en_US
dc.identifier.issn0165-5728
dc.identifier.issue2en_US
dc.identifier.startpage137en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12712/19141
dc.identifier.volume203en_US
dc.identifier.wosWOS:000261270600038
dc.language.isoenen_US
dc.publisherElsevier Science BVen_US
dc.relation.journalJournal of Neuroimmunologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleSoluble TRAIL and BAFF Levels in Multiple Sclerosis During Interferon-Beta Therapyen_US
dc.typeConference Objecten_US
dspace.entity.typePublication

Files